Brief: Journey Medical Corporation Announces Publication In The Journal Of The American Medical Association - Dermatology Of The Phase 3 Clinical Trial Results Of Emrosi™ (Dfd-29) To Treat Rosacea
05/03/2025 22:23
March 5 (Reuters) - Journey Medical Corp DERM.O: JOURNEY MEDICAL CORPORATION ANNOUNCES PUBLICATION IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION - DERMATOLOGY OF THE PHASE 3 CLINICAL TRIAL RESULTS OF EMROSI™ (DFD-29) TO TREAT ROSACEA Source text: ID:nGNXbJ7zqf Further company coverage: DERM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies